How effective are strategies for non-communicable disease prevention and control in a high risk population in a developing country? Isfahan Healthy Heart Programme

Archives of Medical Science

Volumn 6, Issue 1, 2010, Pages 24-31

  Baghaei, Abdolmehdi ^a   Sarrafzadegan, Nizal ^a   Rabiei, Katayoun ^a   Gharipour, Mojgan ^a   Tavasoli, Ali Akbar ^a   Shirani, Shahin ^a   Bahonar, Ahamad ^a   Davarpanah, Amir Hossein ^a   Ramezani, Mohammad Arash ^a   Kelishadi, Roya ^a  

^a Isfahan Cardiovascular Research Center   (Iran)

Author keywords

Community interventions; Coronary artery disease; Developing country; Healthy lifestyle; Iran; Risk factor

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE CONTROL; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY;

EID: 77949474669     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13503     Document Type: Article

References (38)

1. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health, 1996.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular disease. Part I: general considerations, the epidemiologic transition, risk factors and the impact of urbanization. Circulation 2001; 104: 2746-53.
3. Yusuf S, Hawken S, Npuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
4. Sarraf-Zadegan N, Sadri G, Malek Afzali H, et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 2003; 58: 309-20.
5. National Burden of Disease study 2003. Burden of diaeses and risk factors in healthy life expectancy in Islamic Republic of Iran. Ministry of health and medical education, Deputy of Health, Nov 2006.
6. Vasan R, Sullivan L, Wilson P, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 2005; 142: 393-402.
7. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290: 898-904.
8. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282: 2012-8.
9. Grundy SM. Primary prevention of coronary heart disease: integrating risk assessment with intervention. Circulation 1999; 100: 988-98.
10. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension 2000; 35: 858-63.
11. Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA 2003; 290: 947-9.
12. Keil U. Coronary artery disease: the role of lipids, hypertension and smoking. Basic Res Cardiol 2000; 95 (Suppl 1): 152-8.
13. Assmann G, Carmena R, Cullen P, et al. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation 1999; 100: 1930-8.
14. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002; 324: 1570-6.
15. Puska P, Vartianen E, Tuomilehto J, Salomaa V, Nissinn A. Changes in premature deaths in Finland: successful longterm prevention of cardiovascular diseases. Bull WHO 1998; 76: 419-25.
16. World Health Organization. Report on the Consultation on Establishing an Integrated Regional Noncommunicable Disease Network, Cairo, Egypt, 24-26 June 2001. Available in: www.who.int/who-em/NCD/027/E/L.
17. Poska P. Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Pub Health Med 2002; 4: 5-7.
18. Sarrafzadegan N, Baghaei A, Sadri G, et al. Isfahan Healthy Heart Program: Evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prev Control 2006; 2: 73-84.
19. Ford ES, Ford MA, Will JC, Galuska DA, Ballew C. Achieving a healthy life style among United States adults: a long way to go. Ethn Dis 2001; 11: 224-31.
20. Center for Disease Control and Prevention. Prevalence of healthy life style characteristics: Michigan 1998 and 2000. MMWR 2001; 50: 758-61.
21. Greenlund KJ, Zheng ZJ, Keenan NL, et al. Trends in selfreported multiple cardiovascular disease risk factors among adults in the US, 1991-1999. Arch Intern Med 2004; 164: 181-8.
22. Chang M, Mahu RA, Teutsch SM, Hutwagner LC. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the US, 1971-1992. J Clin Epidemiol 2001; 54: 634-44.
23. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U. Cardiovascular Health among Adults in Syria: A Model from Developing Countries. Ann Epidemiol 2007; 17: 713-20.
24. Scientific Position. Risk Factors and Coronary Heart Disease. AHA Scientific Statements on Prevention of Coronary Heart Disease and Stroke. 2007.
25. Keil U, Liese AD, Hense HW, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998; 19: 1197-207.
26. Njolstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med 1998; 158: 1326-32.
27. Greenlund KJ, Zheng ZJ, Keenan NL, et al. Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999. Arch Intern Med 2004; 164: 181-8.
28. st Century. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 2004; 27: 703-9.
29. Ibrahim MM, Rizk H, Appel LJ, et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). Hypertension 1995; 26: 886-90.
30. Lim TO, Morad Z; Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the National Health and Morbidity Survey 1996. Singapore Med J 2004; 45: 20-7.
31. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003; 107: 2185-9.
32. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD. Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. Am J Hypertens 1999; 12: 959-65.
33. Rywik SL, Davis CE, Pajak A, et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities Study. Ann Epidemiol 1998; 8: 3-13.
34. Marques-Vidal P, Evans AE, Cambou JP, et al. Awareness and control of hypertension and hypercholestaerolemia in France and northern Ireland. Q J Med 1997; 90: 341-5.
35. He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004; 110: 405-11.
36. Frontini MG, Srinivasan SR, Elkasabany A, Berenson GS. Awareness of hypertension and dyslipidemia in a semirural population of young adults: the Bogalusa Heart Study. Prev Med 2003; 36: 398-402.
37. Amini M, Aminoroaya A, Rezvanian H, et al. Glycemic control in diabetic patients in Isfahan. Res Med Sci 1997; 2: 8-12.
38. Abazari P, Amini P, Amini M. Management of diabetic patients in Isfahan. Res Med Sci 2001; 2: 102-5.